United Kingdom

People: Prothena Corporation PLC (PRTA.OQ)

PRTA.OQ on NASDAQ Stock Exchange Global Select Market

17 Sep 2019
Change (% chg)

$-0.10 (-1.14%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cooke, Shane 

Mr. Shane M. Cooke is Independent Director of Prothena Corporation plc., since December 2012. He is the former President of Alkermes plc (a biopharmaceutical company), a position he held from 2011 to 2018. Prior to that, he served as Head of Elan Drug Technologies and Executive Vice President of Elan Corporation, plc (from 2007 to 2011), where he also served as Chief Financial Officer (from 2001 to 2011) and as a director (from 2005 to 2011). Mr. Cooke has also held a number of senior positions in finance in the banking and aviation industries. He is also a director of Alkermes plc and Endo International plc. Mr. Cooke earned his Bachelor of Commerce and Master of Accounting degrees from University College Dublin, Ireland, and is a chartered accountant. He has served on our Board since 2012.

Basic Compensation

Total Annual Compensation, USD 74,370
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 435,067
Fiscal Year Total, USD 509,437

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Lars Ekman


Gene Kinney


Tran Nguyen


Karin Walker


Wagner Zago


Carol Karp

As Of  31 Dec 2017